PROGRAF 5 MG Israel - English - Ministry of Health

prograf 5 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

PROGRAF 5 MG Israel - English - Ministry of Health

prograf 5 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

PROGRAF 0.5 MG Israel - English - Ministry of Health

prograf 0.5 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

PROGRAF 0.5 MG Israel - English - Ministry of Health

prograf 0.5 mg

astellas pharma international b.v., israel - tacrolimus - capsules - tacrolimus 0.5 mg - tacrolimus - tacrolimus - prophylaxis of transplant rejection in liver kidney or heart allograft recipients. treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products.

Protopy European Union - English - EMA (European Medicines Agency)

protopy

astellas pharma gmbh - tacrolimus - dermatitis, atopic - other dermatological preparations - treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. treatment of moderate to severe atopic dermatitis in children (2 years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids.maintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

Vesitirim 5 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

vesitirim 5 mg film-coated tablets

astellas pharma co. limited - solifenacin succinate - film-coated tablet - 5 milligram(s) - drugs for urinary frequency and incontinence; solifenacin

Vesitirim 10 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

vesitirim 10 mg film-coated tablets

astellas pharma co. limited - solifenacin succinate - film-coated tablet - 10 milligram(s) - drugs for urinary frequency and incontinence; solifenacin

Vesomni 6 mg/0.4 mg modified-release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

vesomni 6 mg/0.4 mg modified-release tablets

astellas pharma co. limited - solifenacin succinate; tamsulosin hydrochloride - modified-release tablet - 6 mg/0.4 milligram(s) - drugs for urinary frequency and incontinence; solifenacin

Omnexel®, 400 micrograms prolonged release tablets, film-coated Ireland - English - HPRA (Health Products Regulatory Authority)

omnexel®, 400 micrograms prolonged release tablets, film-coated

astellas pharma co. limited - tamsulosin hydrochloride - prolonged-release tablet - 400 microgram(s) - alpha-adrenoreceptor antagonists; tamsulosin

VESIKUR Tablets 5 Milligram Ireland - English - HPRA (Health Products Regulatory Authority)

vesikur tablets 5 milligram

astellas pharma co. ltd - solifenacin succinate - tablets - 5 milligram